This news article was originally written in Spanish. It has been automatically translated for your convenience. Reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace a human translator. The original article in Spanish can be viewed at Merck distribuirá la sucralosa de Tate&Lyle en el mercado farmacéutico
Merck will distribute the Tate & Lyle sucralose in the pharmaceutical market
25/02/2009
February 25, 2009
The company chemical pharmaceutical German Merck and Tate & Lyle have signed an agreement whereby Merck acquires the rights for the distribution of sucralose in the global pharmaceutical market.
Tate & Lyle is the original creator of sucralose, a sweetener that is used as a substitute for sugar in the pharmaceutical industry, among others. This substance is a high intensity sweetener made from conventional sugar. Although its flavor is similar to the of sucrose, get to be up to 600 times sweeter than this. It also has the advantage that the body does not recognize as sugar or as a carbohydrate, so in addition to not providing calories, can consume safely diabetics, children, pregnant women, or older people it.
Merck will market, through its Merck Chemicals Division, the sweetener available in the form of powder and granules, under its own brand as of April 1.
Sucralose can consume it safely with diabetes, children, pregnant women or older people.
